Detalhe da pesquisa
1.
Development & validation of scales to assess stigma related to COVID-19 in India.
Indian J Med Res
; 155(1): 156-164, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859441
2.
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
PLoS Med
; 18(12): e1003877, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890407
3.
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
Indian J Med Res
; 152(1 & 2): 48-60, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32952144
4.
Gender differences in COVID-19 knowledge, risk perception, and public stigma among the general community: Findings from a nationwide cross-sectional study in India.
Int J Disaster Risk Reduct
; 93: 103776, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37303828
5.
Prevalence and factors associated with tuberculosis infection in India.
J Infect Public Health
; 16(12): 2058-2065, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37948837
6.
Factors associated with COVID-19 stigma during the onset of the global pandemic in India: A cross-sectional study.
Front Public Health
; 10: 992046, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36311615
7.
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.
Int J Infect Dis
; 108: 145-155, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34022338
8.
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Lancet Glob Health
; 9(3): e257-e266, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33515512
9.
Development & validation of scales to assess stigma related to COVID-19 in India
Artigo
| IMSEAR | ID: sea-223584